Last update:
Medications news
Medications
Q&A: The economic forces that drive prescription drug prices
Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.
16 hours ago
0
0
Medications
FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
Oct 31, 2025
0
1
Antidepressants improve core depressive symptoms early on, analysis finds
One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major clinical trial led by ...
Oct 30, 2025
0
6
Experimental cancer drug shows exceptional tumor-fighting potential
A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the study introduces a highly ...
Oct 30, 2025
0
0
Atorvastatin recall may affect hundreds of thousands of patients, and reflects FDA's troubles
If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.
Oct 30, 2025
0
1
Women folk healers were branded as witches, but their treatments may have been medically sound
"Double double toil and trouble" is a quote from Shakespeare's Macbeth that conjures images of evil witches making potions in giant cauldrons. But the truth was that women persecuted as witches were probably legitimate healers ...
Oct 30, 2025
0
26
From antibiotics to antimalarials: How repurposed drugs might keep cancer from returning
Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, sometimes years later. ...
Oct 30, 2025
0
0
Chemists design candidate drug against diabetes
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.
Oct 29, 2025
0
13
New technology restores chemotherapy effectiveness against resistant cancer cells
Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.
Oct 29, 2025
0
11
Antibiotics linked to lower risk of complications after obstetric tear
Giving antibiotics to women within 24 hours of an obstetric tear during childbirth is associated with a reduced risk of larger/clinically relevant wound complications, find the results of a clinical trial from Denmark published ...
Oct 29, 2025
0
0
GLP-1 drugs effective for weight loss, but more independent studies needed
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform ...
Oct 29, 2025
0
0
Q&A: New drug being reviewed by the FDA to treat Parkinson's disease
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements.
Oct 29, 2025
0
5
US aims to quicken approvals for cheaper versions of complex drugs
The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and diabetes.
Oct 29, 2025
0
0
New imaging technique maps drug movement through skin in minutes
By combining mass spectrometry imaging with an automated analysis tool, researchers from Hebrew University have developed a technique that maps medication distribution across skin layers without dyes or labels. Tested on ...
Oct 29, 2025
0
0
Home treatment with IV antibiotics could relieve NHS pressure
Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve pressure on hospital beds—according to a University of East Anglia study.
Oct 29, 2025
0
0
Drugs approved for treating pain may also reduce bone cancer growth
Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors called osteosarcomas, ...
Oct 28, 2025
0
53
FDA approves Tezspire for chronic rhinosinusitis with nasal polyps
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients ...
Oct 28, 2025
0
0
Whole tablets may be safer than crushed ones for patients with poststroke swallowing disorders
For decades, stroke patients with swallowing difficulties have routinely received crushed tablets to reduce the risk of aspiration. New clinical data now challenge this practice. A study using endoscopic swallowing diagnostics ...
Oct 28, 2025
0
0
Efforts to promote safer opioid prescribing in Canada appear to be having an effect
Efforts to promote safer opioid prescribing in Canada appear to be having an effect, as new research in the Canadian Medical Association Journal shows a decrease in opioid dispensing between 2018 and 2022.
Oct 27, 2025
0
0
Experimental inhibitor reduces cell death in models of life-threatening skin reactions
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Oct 24, 2025
0
4
New drug tested in mice could fill treatment void for most severe heart attack patients
A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage following severe heart attacks, and promote repair. This could be a game-changer in treating the ...
Oct 24, 2025
0
1
Parent opioid prescriptions linked to teen and young adult opioid use
If a parent has persistent opioid prescriptions, their adolescent or young adult offspring has more than double the risk of persistent opioid use, according to a new study published in PLOS Medicine by Anna Marcuzzi of the ...
Oct 23, 2025
0
6
Psilocybin + mindfulness show promise for health care worker depression
Front-line health care workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group therapy with mindfulness training, according to a new study ...
Oct 23, 2025
0
20
Experimental targeted therapy shows promise for histiocytosis, a rare blood cancer
The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He had a rare blood cancer called Erdheim-Chester disease, and his symptoms included crushing fatigue, severe ...
Oct 23, 2025
0
0
Novel drug combinations pave the way for personalized leukemia therapies
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a review on BH3 mimetics—a new class of drugs that are reshaping the treatment landscape for acute myeloid ...
Oct 23, 2025
0
0
